Researchers have demonstrated new mechanisms in muscle cells that may explain severe insulin resistance and a reduced response to aerobic exercise in young obese patients with type 2 diabetes. These findings may contribute to the development of more specific treatments for young people with type 2 diabetes. (Source: ScienceDaily Headlines)

Scientists in Cambridge have shown that an 'artificial pancreas' can be used to regulate blood glucose in children with Type 1 diabetes. A trial found that combining a real-time sensor measuring glucose levels with a pump that delivers insulin can boost overnight blood glucose control... (Source: Diabetes News From Medical News Today)

Scientists in Cambridge have shown that an 'artificial pancreas' can be used to regulate blood glucose in children with Type 1 diabetes. A trial found that combining a real-time sensor measuring glucose levels with a pump that delivers insulin can boost overnight blood glucose control. The Lancet study showed the device significantly cuts the risk of blood glucose levels dropping dangerously low. In total, 17 children and teenagers with Type 1 diabetes took part in the study over 54 nights in hospital... (Source: Health News from Medical News Today)

Conclusion A pharmacy intervention program in a primary care setting was associated with a significant increase in prescriber adherence to ADA guidelines for ACE inhibitor or ARB therapy and for aspirin therapy in diabetic patients. PMID: 20133534 [PubMed - in process] (Source: American Journal of Health-System Pharmacy : AJHP)

Conclusion An employer-based pharmacist intervention model for patients with diabetes improved HbA(1c) levels, reduced systolic and diastolic blood pressure values, and decreased hospitalizations and emergency room visits after one year. PMID: 20133537 [PubMed - in process] (Source: American Journal of Health-System Pharmacy : AJHP)

Exp Clin Endocrinol Diabetes 2010; 118: 68-68DOI: 10.1055/s-0029-1243234© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New YorkGet connected:Table of contents  |  Full text (Source: Experimental and Clinical Endocrinology and Diabetes)

Exp Clin Endocrinol Diabetes 2010; 118: 1-3DOI: 10.1055/s-0029-1246117AbstractRecently published data examining the role of the metabolic syndrome and obesity in cardiovascular disease rendered suprising results. In addition, other studies revealed that there is more to diabetes therapy than lowering blood glucose, which might under certain circumstances even harm patients. In the light that we now know that “death” is as important an endpoint in diabetes as in other diseases, new tools – better than the oral glucose tolerance test – are required to identify the patients at risk, as are additional standards in individualized therapy. A critical view on old concepts is necessary.[...]© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New YorkGet connected:T...

Conclusions: In type 2 diabetic subjects, glycaemic control shows a significant correlation with well-being, while neuropathic pain is associated with lower well-being score.[...]© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New YorkGet connected:Table of contents  |  Abstract  |  Full text (Source: Experimental and Clinical Endocrinology and Diabetes)

Exp Clin Endocrinol DiabetesDOI: 10.1055/s-0029-1246213Abstract To determine the prevalence of genetic risk markers of type 1 diabetes (T1D) in children diagnosed at a single centre in Germany and to assess their relation to diabetes-associated autoantibodies.[...]© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New YorkGet connected:Table of contents  |  Abstract  |  Full text (Source: Experimental and Clinical Endocrinology and Diabetes)

Exp Clin Endocrinol DiabetesDOI: 10.1055/s-0030-1249005© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New YorkGet connected:Table of contents  |  FREE: Full text (Source: Experimental and Clinical Endocrinology and Diabetes)